期刊文献+

维持性血液透析患者血清镁和血脂代谢的相关研究 被引量:3

Relationship between serum lipids and serum magnesium in maintenance hemodialysis patients
暂未订购
导出
摘要 目的探讨维持性血液透析患者的血脂代谢与血清镁之间的关系。方法对60例行血液透析的患者检测总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、血清镁(Mg),应用相关分析和t检验对血清镁与血脂各项指标的关系进行统计学分析。结果血清镁水平与HDL-C呈正相关(P<0.05);血清镁水平与LDL-C呈负相关(P<0.05);血清镁与TG、TC的相关性无统计学意义(P>0.05)。结论脂代谢异常是维持性血液透析患者常见的并发症,血清镁水平可能与脂代谢异常有一定的相关性。 Objective This study was performed to determine the correlation between serum magnesium(Mg) and lipid in patients on maintenance hemodialysis(MHD).Methods Blood levels of TC,TG,HDL-C,LDL-C,Mg were measured in 60 maintenance hemodialysis patients.The application of correlation analysis and t test were statistically analyzed the relationship between serum magnesium and serum lipid indicators.Results There was positive correlation between serum magnesium and serum HDL-C,while there was negative correlation between serum magnesium and serum LDL-C(P0.05).There was no significant correlation between serum magnesium and serum TC,TG.Conclusion Dyslipidemia is the frequent complications in maintenance hemodialysis patients.The level of Mg may have correlation with the dyslipidemia.
出处 《四川医学》 CAS 2012年第10期1819-1820,共2页 Sichuan Medical Journal
关键词 血液透析 血脂 hemodialysis magnesium blood lipid
  • 相关文献

参考文献7

  • 1AI Wakeel JS, Mitwalli AH, A1 Mohaya S, et al. Morbidity and mor- tality in ESRD patients on dialysis[J]. Saudi J Kidney Dis Transpl , 2002,13 (4) :473 -477.
  • 2Rasmusson HS. Influence of Magnesium substitution Therapy on Blood Lipid Composition in Patient with Ischemic Heart Disease [ J ]. Arch Intem Med, 1989,149 (5) : 1050 - 1053.
  • 3赵战芝,杨永宗.低镁血症在动脉粥样硬化发病中的作用[J].心血管病学进展,2004,25(6):450-453. 被引量:9
  • 4Song Y, He K, Levitan EB, et al. Effects of oral magnesium supplemen- tation on glycaemlc control in Type 2 diabetes:a meta-analysis of ran- domized double-blind on trolled trials[ J]. Diabet Med ,2006,23 (10) : 1050 - 1056.
  • 5Muhammad Rafique Ansafi, Narinder Maheshwari, et al. Correlation of serum magnesium with dyslipidemia in patients on maintenance he- modialysis[ J]. Saudi J Kidney Dis Transpl, 2012, 23 ( 1 ) :21 -25.
  • 6lnoul. Lipid metabolism and magnesium [ J]. Clin Calcium,2005,15 (11):65-76.
  • 7陈军,黄国明.镁与动脉粥样硬化[J].国际内科学杂志,2007,34(7):394-396. 被引量:4

二级参考文献20

  • 1Kisters K,Tokmak F,Gremmler B,et al,Increased calcium/magnesium ratio in young and old spontaneously hypertensive rats:Pathogenetic factor in the development of hypertension and vascular fibrasis.Am J Hypertens,2005,18(2):295-299.
  • 2Kisters K,Wessels F,Kuper H,et al.Increased calcium and decreased magnesium concentrations and an increased calcium/magnesium ratio in spontaneously hypertensive rats versus Wistar.Kvoto rats:relation to arteriosclerosis.Am J Hypertens,2004,17(1):59-62.
  • 3Pitero D.Magnesium and coronary heart disese.Mol Aspects Med,2003,24:63-78.
  • 4Tatsuo S,Koji T,Katsuyki A,et al.Magnesium inhibits norepinephrine release by blocking n-type calcium channels at peripheral sympathetic nerve endings.Hypertension,2004,44(6):897-902.
  • 5Nathalie B,Pascl L,Dominique F,et al.Effect of Magnesium on mRNA Expression and Production of Endothelin-1 in DOCA-Salt Hypertensive Rats.J Cardiovasc Pharlnacol,2003,42(1):24-31.
  • 6He Ying,Yao GY,Carmine S,et al.Transient Peceptor Potential Melastatin 7 Ion Channels Regulate Magnesium Homeostasis in Vascular Smooth Muscle Cells:Role of Angiotensin-Ⅱ.Circ Res,2005,96(2):207-215.
  • 7Altura BT,Brust M,Bloom S,et al.Magnesium dietary intake modulates bloodlipid level and athetogensis.Proc Natl Acad Sci U S A,1990,87(5):1840-1844.
  • 8Yamaguchi Y,Kitagawa S,Kunitomo M,et al.Preventive effects of magnesiumon raised serum lipid peroxide levels and aortic deposition in mice fed an atherogenic diet.Magnes Res.1994,7:31-37.
  • 9Ravn HB,Korscholm TL,Falk E.Oral magnesium supplementation induces antiatherogenic changes in APO-E deficien mice.Arterioseler Thromb Vase Biol,2001,21(5):858-862.
  • 10Inou I.Lipid metabolism and magne sium.Clin Calcium,2005,15(11):65-76.

共引文献10

同被引文献34

  • 1余学清,沈清端,李惠群,董秀清.不同透析方法对透析病者血浆脂蛋白和载脂蛋白的影响[J].中山医科大学学报,1996,17(2):120-125. 被引量:14
  • 2曾石养,苏卫东,薛志强.终末期肾衰竭透析患者血脂变化的临床意义[J].现代医药卫生,2006,22(15):2260-2261. 被引量:4
  • 3Tsimihodimos V, Dounousi E, Siamopoulos K C.Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treat- ment[J]. Am J Nephrol,2008,28(6):958-973.
  • 4Mitwalli A H, Alam A A, AI Wakeel J S. Dyslipidemia in dialysis patient[J].Saudi J Kidney Dis Transpl,2011,22(4):689-694.
  • 5Jean G. How to manage mineral metabolism disorders in renalfailure[J].Presse Med,2011,40(11):1043-1052.
  • 6Goodman W G, Goldin J, Kuizon B D, et al. Coronary-artery cal- cification in young adults with end-stage renal disease who are undergoing dialysis[J]. N Engl J Med,2000,342: 1478-1483.
  • 7Turgut F, Kanbay M. Magnesium supplementation helps to im- prove carotid intima media thickness in patients on hemodialysis [J]. Int Urol Nephrol, 2008,40(4):1075-1082.
  • 8Tzanakis I, Virvidakis K, Tsomi A, et al. Intra- and extracellular magnesium levels and afheromatosis in haemodialysis patients [J]. Magnes Res, 2004,17(2): 102-108.
  • 9Inoul. Lipid metabolism and magnesium[J]. Clin Calcium, 2005, 15(11):65 - 76.
  • 10Rosanoff A, Seeling M S. Comparison of mechanism and fun-ctional effects of magnesium and statin pharmaceuticals[J]. Am Coil Nutr,2004,23(5):501S-505S.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部